1. Relation between recurrence and expression of proliferating cell nuclear antigen, sialyl Lewis X, and sialyl Lewis a in lung cancer 
Jun-ichi Ogawa, MD, Akemi Sano, Sirosaku Koide, MD, Akira Shohtsu, MD 
The Journal of Thoracic and Cardiovascular Surgery 
Volume 108, Issue 2, Pages (August 1994)
DOI: /uri:pii:S X
Copyright © 1994 Mosby, Inc. Terms and Conditions

2. Fig. 1
Disease-free survival according to blood vessel invasion (BVI), expression of sialyl LewisX (SLX), and proliferating cell nuclear antigen (PCNA) in adenocarcinomas. (p < 0.03: BVI (+) SLX (-, +) PCNA (+) versus BVI (+) SLX (++) PCNA (++). Fig. 1. Cont'd. Disease-free survival according to blood vessel invasion (BVI), sialyl Lewisa (CA19-9), and proliferating cell nuclear antigen (PCNA) in non-adenocarcinomas. p < 0.05: BVI(+) CA19-9 (–, +) PCNA (+) versus BVI (+) CA19-9 (++) PCNA (++).
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /uri:pii:S X)
Copyright © 1994 Mosby, Inc. Terms and Conditions

3. Fig. 1
Disease-free survival according to blood vessel invasion (BVI), expression of sialyl LewisX (SLX), and proliferating cell nuclear antigen (PCNA) in adenocarcinomas. (p < 0.03: BVI (+) SLX (-, +) PCNA (+) versus BVI (+) SLX (++) PCNA (++). Fig. 1. Cont'd. Disease-free survival according to blood vessel invasion (BVI), sialyl Lewisa (CA19-9), and proliferating cell nuclear antigen (PCNA) in non-adenocarcinomas. p < 0.05: BVI(+) CA19-9 (–, +) PCNA (+) versus BVI (+) CA19-9 (++) PCNA (++).
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /uri:pii:S X)
Copyright © 1994 Mosby, Inc. Terms and Conditions

4. Fig. 2
Disease-free survival in patients with recurrent tumors according to expression of proliferating cell nuclear antigen (PCNA) in adenocarcinomas. p < 0.01: PCNA (+) versus PCNA (++). Fig. 2. Cont'd Disease-free survival in the patients with recurrent tumors according to expression of proliferating cell nuclear antigen (PCNA) in nonadenocarcinomas. p < 0.01: PCNA (+) versus PCNA (++).
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /uri:pii:S X)
Copyright © 1994 Mosby, Inc. Terms and Conditions

5. Fig. 2
Disease-free survival in patients with recurrent tumors according to expression of proliferating cell nuclear antigen (PCNA) in adenocarcinomas. p < 0.01: PCNA (+) versus PCNA (++). Fig. 2. Cont'd Disease-free survival in the patients with recurrent tumors according to expression of proliferating cell nuclear antigen (PCNA) in nonadenocarcinomas. p < 0.01: PCNA (+) versus PCNA (++).
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /uri:pii:S X)
Copyright © 1994 Mosby, Inc. Terms and Conditions